An in-depth look to SYNGEN BIOTECH CO LTD operating, investing, and financing activities

8279 free cash flow for Q3 24 is 155.07 M TWD. For 2023, 8279 free cash flow was 369.55 M TWD and operating cash flow was 461.45 M TWD.